These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 39009937)

  • 1. Correction to: SARS-CoV-2 S-Protein-Ace2 Binding Analysis Using Surface Plasmon Resonance.
    Baardsnes J; Paul-Roc B
    Methods Mol Biol; 2024; 2762():C1. PubMed ID: 39009937
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2S-Protein-Ace2 Binding Analysis Using Surface Plasmon Resonance.
    Baardsnes J; Paul-Roc B
    Methods Mol Biol; 2024; 2762():71-87. PubMed ID: 38315360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free Analysis of Binding and Inhibition of SARS-Cov-19 Spike Proteins to ACE2 Receptor with ACE2-Derived Peptides by Surface Plasmon Resonance.
    Abouhajar F; Chaudhuri R; Valiulis SN; Stuart DD; Malinick AS; Xue M; Cheng Q
    ACS Appl Bio Mater; 2023 Jan; 6(1):182-190. PubMed ID: 36550079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction.
    Xiong J; Xiang Y; Huang Z; Liu X; Wang M; Ge G; Chen H; Xu J; Zheng M; Chen L
    Front Chem; 2021; 9():740702. PubMed ID: 34646813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology.
    Zhu ZL; Qiu XD; Wu S; Liu YT; Zhao T; Sun ZH; Li ZR; Shan GZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.
    Ma LL; Liu HM; Liu XM; Yuan XY; Xu C; Wang F; Lin JZ; Xu RC; Zhang DK
    Eur J Med Chem; 2021 Dec; 226():113857. PubMed ID: 34628234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.
    Pan B; Fang S; Zhang J; Pan Y; Liu H; Wang Y; Li M; Liu L
    Comput Struct Biotechnol J; 2020; 18():3518-3527. PubMed ID: 33200026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
    Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
    J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    bioRxiv; 2021 Oct; ():. PubMed ID: 34729559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.
    Liu S; Chen H; Chen X; Luo N; Peraramelli S; Gong X; Zhang MJ; Ou L
    Front Immunol; 2024; 15():1365803. PubMed ID: 38646520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics.
    Kelaidonis K; Ligielli I; Letsios S; Vidali VP; Mavromoustakos T; Vassilaki N; Moore GJ; Hoffmann W; Węgrzyn K; Ridgway H; Chasapis CT; Matsoukas JM
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2.
    Pavan M; Fanti CD; Lucia AD; Canato E; Acquasaliente L; Sonvico F; Delgado J; Hicks A; Torrelles JB; Kulkarni V; Dwivedi V; Zanellato AM; Galesso D; Pasut G; Buttini F; Martinez-Sobrido L; Guarise C
    Eur J Pharm Sci; 2023 Aug; 187():106489. PubMed ID: 37311533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain.
    Zhou X; Zhao J; Qiu Y; Jia R
    Biosaf Health; 2022 Oct; 4(5):293-298. PubMed ID: 36105891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Dynamics of SARS-CoV-2 Mutations: Insights from Surface Plasmon Resonance Biosensor Kinetics.
    Nurrohman DT; Chiu NF
    Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors.
    Kiew LV; Chang CY; Huang SY; Wang PW; Heh CH; Liu CT; Cheng CH; Lu YX; Chen YC; Huang YX; Chang SY; Tsai HY; Kung YA; Huang PN; Hsu MH; Leo BF; Foo YY; Su CH; Hsu KC; Huang PH; Ng CJ; Kamarulzaman A; Yuan CJ; Shieh DB; Shih SR; Chung LY; Chang CC
    Biosens Bioelectron; 2021 Jul; 183():113213. PubMed ID: 33857754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.